tomi™ environmental solutions, inc. is a global bacteria decontamination and infectious disease control company, providing environmental solutions for indoor surface decontamination through manufacturing, sales, and licensing of our premier platform of hydrogen peroxide based products that use binary ionization technology® (bit™), a state of the art technology for the production of its disinfectant/decontaminate mist/fog represented by the tomi™ steramist™ brand. binary ionization technology® (bit™) and its steramist™ platform was developed in conjunction with the defense advanced research projects agency (darpa) and a large u.s. defense contractor, in response to amerithrax (anthrax attacks) post 9/11/2001 to deal with an array of chemical and biological threats while safe for use on a wide variety of materials, including delicate electronics. binary ionization technology® (bit™) is a patented two-step process that activates and ionizes a 7.8% hydrogen peroxide solution. the fine mist
Company profile
Ticker
TOMZ
Exchange
Website
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Ozone Man, Inc., RPS GROUP INC, DAUPHIN INC
SEC CIK
Corporate docs
IRS number
591947988
TOMZ stock data
Latest filings (excl ownership)
8-K
Tomi Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2023 Financial Results
1 Apr 24
10-K
2023 FY
Annual report
1 Apr 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
22 Feb 24
EFFECT
Notice of effectiveness
10 Jan 24
CORRESP
Correspondence with SEC
5 Jan 24
UPLOAD
Letter from SEC
4 Jan 24
S-3
Shelf registration
26 Dec 23
D
$5.00 mm in debt / options, sold $2.60 mm, 28 investors
28 Nov 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Tomi Environmental Solutions, Inc. Reports Third Quarter Financial Results
14 Nov 23
Transcripts
TOMZ
Earnings call transcript
2023 Q4
1 Apr 24
TOMZ
Earnings call transcript
2023 Q3
14 Nov 23
TOMZ
Earnings call transcript
2023 Q2
14 Aug 23
TOMZ
Earnings call transcript
2023 Q2
11 Aug 23
TOMZ
Earnings call transcript
2023 Q1
15 May 23
TOMZ
Earnings call transcript
2022 Q4
16 Mar 23
TOMZ
Earnings call transcript
2022 Q3
14 Nov 22
TOMZ
Earnings call transcript
2022 Q2
16 Aug 22
TOMZ
Earnings call transcript
2022 Q1
9 May 22
TOMZ
Earnings call transcript
2021 Q4
30 Mar 22
Latest ownership filings
4
Elissa Jessica Shane
8 Jan 24
4
Dr. Halden Stuart Shane
23 Aug 23
4
Dr. Halden Stuart Shane
21 Aug 23
4
Dr. Halden Stuart Shane
27 Jan 23
4
Elissa Jessica Shane
27 Jan 23
4
Nick Jennings
27 Jan 23
4
Boh Soon Lim
27 Jan 23
4
Kelly Anderson
27 Jan 23
4
WALTER C JOHNSEN
27 Jan 23
4
Dr. Halden Stuart Shane
20 Jul 22
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.41 mm | 1.41 mm | 1.41 mm | 1.41 mm | 1.41 mm | 1.41 mm |
Cash burn (monthly) | 54.46 k | 243.73 k | 300.35 k | 240.34 k | 54.46 k | 222.27 k |
Cash used (since last report) | 375.30 k | 1.68 mm | 2.07 mm | 1.66 mm | 375.30 k | 1.53 mm |
Cash remaining | 1.04 mm | -268.81 k | -658.92 k | -245.42 k | 1.04 mm | -120.90 k |
Runway (months of cash) | 19.0 | -1.1 | -2.2 | -1.0 | 19.0 | -0.5 |
Institutional ownership, Q3 2023
4.5% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 16 |
Opened positions | 2 |
Closed positions | 2 |
Increased positions | 5 |
Reduced positions | 2 |
13F shares | Current |
---|---|
Total value | 775.72 mm |
Total shares | 906.47 k |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 554.26 k | $493.55 mm |
Geode Capital Management | 113.05 k | $98.38 mm |
Scarborough Advisors | 93.75 k | $83.48 mm |
STT State Street | 52.21 k | $45.42 mm |
Renaissance Technologies | 30.99 k | $28.00 k |
Dynamic Advisor Solutions | 20.00 k | $17.81 mm |
NTRS Northern Trust | 15.84 k | $14.10 mm |
Natixis | 8.83 k | $7.33 mm |
Tower Research Capital | 8.58 k | $7.64 mm |
MS Morgan Stanley | 3.43 k | $3.05 mm |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 24 | Shane Elissa Jessica | Common Stock Purchase Options Common Stock | Conversion | Dispose C | No | No | 0.88 | 31,250 | 27.50 k | 188,750 |
22 Aug 23 | Shane Dr. Halden Stuart | Common Stock | Buy | Acquire P | No | No | 1.2 | 2,503 | 3.00 k | 2,538,166 |
18 Aug 23 | Shane Dr. Halden Stuart | Common Stock | Buy | Acquire P | No | No | 1.07 | 3,000 | 3.21 k | 2,535,663 |
26 Jan 23 | Johnsen Walter C | Common Stock | Grant | Acquire A | No | No | 0.85 | 20,000 | 17.00 k | 90,375 |
26 Jan 23 | Boh Soon Lim | Common Stock | Grant | Acquire A | No | No | 0.85 | 20,000 | 17.00 k | 148,524 |
News
12 Industrials Stocks Moving In Friday's Intraday Session
12 Apr 24
HC Wainwright & Co. Reiterates Buy on TOMI Environmental Solns, Maintains $3.5 Price Target
3 Apr 24
TOMI Environmental Solns: Q4 Earnings Insights
1 Apr 24
TOMI Environmental Solns Q4 EPS $(0.06) Misses $(0.01) Estimate, Sales $1.53M Miss $2.86M Estimate
1 Apr 24
Earnings Scheduled For April 1, 2024
1 Apr 24
Press releases
TOMI Environmental Solutions to Attend Interphex 2024
15 Apr 24
TOMI Environmental Solutions Receives Gold Safety Award from Highwire
3 Apr 24
TOMI Environmental Solutions, Inc. Reports Fourth Quarter and Year End 2023 Financial Results
1 Apr 24
TOMI Environmental Solutions, Inc. to Hold Conference Call to Discuss Fourth Quarter 2023 Financial Results on April 1, 2024
26 Mar 24
Study on Foot-and-Mouth Disease Virus Results in Submission for Additional EPA Label
11 Mar 24